A Pilot Study of Delivering 'Engage' Psychotherapy Via Telemedicine Through the Tablet-based 'Prism' System to Homebound Older Adults With Depression
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Depression
- Sponsor
- Weill Medical College of Cornell University
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Feasibility: Client Enrollment
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.
Detailed Description
Engage is a brief therapy designed to offer a structured, stepped approach and interventions to reduce barriers to increased engagement with rewarding activities to improve depression (Alexopoulos et al, 2020). The goal is to increase participation in meaningful activities. Homebound older adults have limited social interaction given their restricted mobility and medical burden. In prior research with an intervention targeting social engagement with a technology intervention (PRISM 2.0), participants reported increased social support, decreased loneliness, increased feelings of well-being, more positive attitudes about computers, and gains in computer proficiency (Czaja et al., 2017). Participants will be referrals from case management service. Clinicians will incorporate elements of the Prism system into therapy as appropriate, and participants will be instructed to use the Prism system at their leisure or as it pertains to their chosen "reward exposure" activities. There will be a post-therapy assessment and interview about their experience with the technology at week 9. The study will conclude with follow-up assessments at week 12.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age at least 60 years
- •English speaking
- •Currently enrolled in case management at in 2 included agencies
- •Major depression on the SCID
- •24-item Hamilton Depression Rating Scale (HAM-D) ≥ 19
Exclusion Criteria
- •Psychotic depression by SCID-V, i.e. presence of delusions
- •High suicide risk, i.e. intent or plan to attempt suicide in the near future
- •Presence of any Axis I psychiatric disorder
- •Presence of substance abuse other than unipolar major depression
- •History of psychiatric disorders, hypomania, are excluded
- •Acute or severe medical illness, i.e. delirium, metastatic cancer, decompensated cardiac, liver, or kidney failure, major surgery, stroke, or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g. steroids, reserpine, alpha- methyl-dopa, tamoxiphen, vincristine
- •Current involvement in psychotherapy
- •Cognitive impairment (i.e. telephone administered MoCA \< 11)
- •Currently dwelling in non-community dwelling (e.g. prison, nursing home)
- •Hearing that would not allow participants to complete sessions with the RA/therapist
Outcomes
Primary Outcomes
Feasibility: Client Enrollment
Time Frame: Baseline
Feasibility will be measured as the number of clients who are referred to the program, meet eligibility and accept the intervention (versus refuse).
Acceptability: Client Satisfaction Questionnaire (CSQ)
Time Frame: 12 weeks (post treatment)
The CSQ is a 3 - item questionnaire assessing client satisfaction with the treatment provided assessed at 3 weeks post treatment (at 12 weeks) Scores range from 3 (least satisfied) to 12 (most satisfied).
Secondary Outcomes
- Hamilton Depression Rating Scale(Baseline, 12 weeks (post treatment))